SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-003110
Filing Date
2017-03-31
Accepted
2017-03-31 08:31:46
Documents
80
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1313714
2 ex31-1.htm EX-31.1 8428
3 ex31-2.htm EX-31.2 8456
4 ex32-1.htm EX-32.1 7944
11 image_001.jpg GRAPHIC 42290
  Complete submission text file 0001493152-17-003110.txt   5494239

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cocp-20161231.xml EX-101.INS 1024133
6 XBRL SCHEMA FILE cocp-20161231.xsd EX-101.SCH 52658
7 XBRL CALCULATION FILE cocp-20161231_cal.xml EX-101.CAL 59405
8 XBRL DEFINITION FILE cocp-20161231_def.xml EX-101.DEF 184654
9 XBRL LABEL FILE cocp-20161231_lab.xml EX-101.LAB 364096
10 XBRL PRESENTATION FILE cocp-20161231_pre.xml EX-101.PRE 305052
Mailing Address 1860 MONTREAL ROAD TUCKER GA 30084
Business Address 1860 MONTREAL ROAD TUCKER GA 30084 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55158 | Film No.: 17728074
SIC: 2834 Pharmaceutical Preparations